should i switch from tirzepatide to retatrutide vs Tirzepatide: 28.7% vs 22.5% (2026) What is the recommended protocol

doi: 10.1016/S0140-6736(20)32511-3 Summary Keywords chronic liver disorder, metabolic syndrome, non-alcoholic fatty liver disease, oxidative stress, oral glutathione Citation Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV and Di Sabatino A (2023) Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease

Old standbys still help, too, like physical therapy, over-the-counter (OTC) anti-inflammatory medications, ice compresses, or topical OTC therapies like Biofreeze

Although some emerging research suggests that GLP-1RAs might reduce binge-eating episodes, there is not yet enough evidence to support their use specifically for treating binge-eating disorder (BED) and its associated psychopathology

PLoS ONE (2014) 9:e101005